You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. PatientCareAnywhere: Patient Support and Empowerment Across the Care Continuum

    SBC: BRIGHTOUTCOME INC.            Topic: 102

    DESCRIPTIONprovided by applicantComprehensive bio psychosocial screeningwhich covers not only physical symptoms and psychosocial issuesbut also practical concerns such as transportationfinanceswork and childcareoffers the true opportunity to maximize the benefits of medical care and social support to patients and their families while enhancing operational efficiency and resource management for hea ...

    SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health
  2. Using an API to commercialize an evidence based weight loss intervention

    SBC: COEUS HEALTH, LLC            Topic: 300

    DESCRIPTION provided by applicant Over percent of the U S population is currently overweight or obese percent are obese Obesity is a primary cause of numerous chronic diseases including type II diabetes cancer heart disease and the metabolic syndrome Behavioral weight loss interventions have successfully resulted in significant clinical improvements in weight percent weight lo ...

    SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health
  3. Colon cancer risk-stratification via optical analysis of rectal ultrastructure

    SBC: American BioOptics, LLC            Topic: NCI

    DESCRIPTIONprovided by applicantThe goal of this small business innovation research grant is to develop and commercialize a highly accurateminimally invasive risk stratification technique for colorectal cancerCRCthat is simple enough to be performed by the primary care provider during an annual physical examAlthough existing guidelines recommend CRC screening for all patients over agertmillion Ame ...

    SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health
  4. Novel Use of Emergent Technologies to Improve Efficiency of Animal Model Research

    SBC: ROCKSTEP SOLUTIONS INC            Topic: 400

    PROJECT SUMMARY This Phase II project aims to continue development of a commercial qualityinnovative cloud hosted information management systemcalled Climbthat will increase laboratory efficiency and provide improved capabilities for research laboratoriesClimb is designed to offer integrated laboratory process management modules that include mobile communications tools data monitoring and alert sy ...

    SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health
  5. Newborn Infant Vision Test

    SBC: Precision Vision, Inc.            Topic: N

    Project Summary! This STTR Phase II project continues the development of the Newborn Acuity Cardstm and the Newborn Contrast Cardstm Together these Newborn Cards form a new clinical test of visual acuity and contrast sensi tivity for use on newborn full term and preterm infants The stimuli are square wave gratings which the examiner presents to the infant in a fixation and following protocol ...

    STTR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health
  6. Aminomethyl benzamides as novel anti Ebola agents

    SBC: Chicago Biosolutions, Inc.            Topic: NIAID

    Ebola EBOV and Marburg MARV viruses belong to the family Filoviridae and can cause fatal hemorrhagic fevers characterized by widespread tissue destruction with an incubation period of days Because of the safety concerns these viruses are designated as the biosafety level agents Currently there is no effective vaccine or therapeutic treatment against filoviral infection and pathogenes ...

    STTR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
  7. Sustained release gel enabling one stage treatment of prosthetic joint infection

    SBC: SONORAN BIOSCIENCES INC            Topic: NIAMS

    Principal Investigator Overstreet Derek J Abstract Sonoran Biosciences Inc SBIR PAR Direct Phase II Prosthetic joint infections PJIs are especially costly requiring two surgeries at a cost of approximately $ per case to treat more than hip and knee replacement infections each year The near term outlook in this area is bleak with the number of infections growing ov ...

    SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health
  8. Better Living After Stroke through Technology BLAST

    SBC: BRIGHTOUTCOME INC.            Topic: 600

    DESCRIPTION provided by applicant Stroke the leading cause of disability cognitive impairment and death in the US imposes significant financial and personal burden The residual effects of stroke affect many aspects of life not addressed by traditional rehabilitation treatments In particular persons with mild stroke typically defined as a stroke with no or sligh motor impairment and a high ...

    SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health
  9. Online professional development training for promotoras on lupus

    SBC: KDH Research & Communication, Inc.            Topic: NIMHD

    DESCRIPTION provided by applicant KDH Research and Communication KDHRC with the American College of Rheumatology ACR will develop LLPI Latinas con Lupus Promotoras con Informaci n Latinas with Lupus Promotoras with Information a culturally competent unique online professional development course course to improve the ability of promotoras de salud promotoras to raise awareness ...

    SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health
  10. Aminopiperidines as novel anti influenza agents

    SBC: Chicago Biosolutions, Inc.            Topic: NIAID

    Influenza A viruses belong to the orthomyxoviridae family with a negative sense segmented RNA genome which can cause seasonal or pandemic flu with high morbidity and significant mortality Vaccination is the most prevalent prophylactic means for controlling influenza infections However an effective vaccine usually takes at least months to develop for the circulating strains Furthermore vac ...

    STTR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government